Bactobio is a London-based biotechnology company using breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to culture the 99% of microbes which have previously been unculturable. Bactobio’s exclusive access to nature’s greatest untapped bioresource allows them to discover novel chemical and biological solutions across the pharmaceutical, agricultural and chemical industries. Their first target is the growing antimicrobial resistance crisis.